Why Array BioPharma Shares Spiked

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case they’re material to our investing thesis.What: Shares of Array BioPharma (NASDAQ: ARRY ) , a biopharmaceutical company focused on the development of small molecule drugs for the treatment of cancer and inflammatory diseases, […]